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Abstract: Objectives: To evaluate the feasibility of Addressing Tobaccos through Organizational Change (ATTOC) in-
tervention to Chinese psychiatric patients, and to better address tobacco use through the ATTOC intervention model 
in the context of China. Methods: The study was conducted in Mental Health Center of West China Hospital in 2010. 
A total of 100 hospitalized psychiatric patients were recruited to carry out ATTOC intervention. Subjects suffers from 
mental illness were diagnosed by professional psychiatrists according to the International Statistical Classification 
of Diseases (ICD-10) criteria. Results: The prevalence of tobacco use in hospitalized psychiatric patients were close-
ly correlated with the type of mental illness, family smoking history, sex, age, marital status, education status, etc. 
However, most psychiatric patients knew little about these, and tended to ignore the importance of smoking cessa-
tion. Conclusions: The ATTOC intervention program of the U.S. may be suitable for hospitalized Chinese psychiatric 
patients, and it could be applied for the tobacco smoking treatment in China. However, the health effects of tobacco 
use still did not draw amount attentions from both the clinicians and general public. It is urgently needed to raise 
people’s awareness and carry out ATTOC intervention to control tobacco use, and ultimately terminate tobacco use.
Keywords: Tobacco use, ATTOC intervention, tobacco prevalence, hospitalized psychiatric patients
Introduction 
Tobacco use is one of the major causes of 
death worldwide which is preventable. The 
emergence of tobacco-related diseases has 
become a burgeoning public health problem. 
According WHO report, there is over one billion 
persons smoke worldwide, and more than 5 
million annual deaths are attributed to tobacco. 
This figure is expected to rise to 10 million in 
2030, with 7 million of death occurring in devel-
oping countries, mainly in China and India [1]. 
Studies indicated that high tobacco-smoking 
rates existed in the patients with psychiatric 
disorders, such as schizophrenia, bipolar disor-
der, depression, and panic disorder [2, 3]. 
Nnicotine dependence, as a substance use dis-
order in tobacco user, was the most prevalent 
and deadly in all psychiatric disorders and was 
often overlooked [4, 5].  
Despite smoking rate has reduced and social 
norms surrounding tobacco use have improved, 
smoking prevalence was still as high as 25% in 
the United States for people have a lifetime his-
tory of nicotine dependence [6], and tobacco 
use persisted as the leading cause of prevent-
able illness and death [7]. As the world’s largest 
tobacco producer and consumer, China home 
approximately one-third of the world’s smokers 
[8]. Despite much progress have achieved in 
tobacco control, the prevalence of tobacco use 
is still high among the Chinese population [9]. 
Cigarette consumption has been reported to 
associate with elevated scores on suicidality in 
bipolar patients [10] and mental illness [11] 
significantly. 
In view of tobacco use and related addiction 
hazards described above, an increasing amount 
of attentions has been focused on tobacco 
smoking and addiction treatment for tobacco 
users [12-14]. There were some specific recom-
mendations provided by physicians and other 
health care professionals to help patients quit 
smoking [15]. As a specific addiction and men-
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tal health treatment program developed by 
Douglas Ziedonis et al. [16], addressing Toba- 
cco through Organizational Change (ATTOC) 
intervention model has been successfully 
implemented in the US to help many tobacco-
addicts. The efficiency of ATTOC model on 
tobacco treatment has been extensively docu-
mented and evaluated by National Institute of 
Health [16]. 
So far, there was no mature intervention sys-
tem available to effectively address tobacco 
use in China, it is important to get the estimat-
ed prevalence of tobacco use, and further 
develop an effective intervention system 
against tobacco use and addiction. In this 
study, to explore whether the ATTOC interven-
tion is suitable for Chinese tobacco users, we 
evaluated the potential efficiency of ATTOC on 
hospitalized psychiatric patients. 
Materials and methods
Patients
The study was designed as a cross-sectional 
survey, and it was carried out in the Mental 
Health Center of West China Hospital of 
Sichuan University. The coordinators of desig-
nated team did pre-intervention evaluations in 
late March to early April 2010, and they were 
responsible for providing questionnaires and 
explanation. In the first stage, the inpatients 
were assessed and diagnosed by senior psy-
chiatrists according to International Statistical 
Classification of Disease system 10th Revision 
(ICD-10). In the second stage, questionnaires 
were distributed to each patient, and then 
reclaimed to conduct Statistics. 
This study was supported by the University of 
Massachusetts Medical School Global 
Initiatives Program and the local ethical review 
board of our institution, and all patients and 
their family members gave their written 
informed consents. The hospitalized patients 
with psychiatric disorders were randomly 
selected from the Mental Health Center of West 
China Hospital of Sichuan University during late 
March to early April of 2010, they voluntarily 
consented to participate; These patients were 
selected from open area ward, they were main-
ly have mild schizophrenia, anxiety and 
depression. 
Patients with unclear consciousness, language 
or hearing problem were excluded from this 
study; patients were excluded if they were in 
closed ward. After a thorough screening, a total 
of 100 psychiatric inpatients were eligible for 
this study, and their smoking status was 
assessed from questionnaires. Patients unable 
to complete the questionnaire independently 
were helped by the clinicians.  
Evaluation methods
For the pre-intervention evaluations, ATTOC-
patient questionnaires were administrated 
between late-March to early-April 2010. The 
mental disorders were assessed and diag-
nosed with ICD-10. The projects contain items 
primarily came from the Knowledge, Attitudes 
and Services Questionnaire (KAS) [17], 
Fagerstrom Test of Nicotine Dependence 
(FTND) [18], and other supplemented items, 
which including concern about tobacco use, 
reasons for tobacco use, symptoms related to 
tobacco use, encounters with a provider about 
the patient’s tobacco use, interest in talking to 
a provider about tobacco use and quitting. 
KAS assessed items such as the using of 
tobacco products, knowledge about the health 
effects of tobacco, interest and confidence in 
quitting, and the receipt of clinician services 
addressing patient tobacco use. The FTND con-
sisting of 6 of the original items (nicotine rating 
and inhalation have been eliminated) with 
revised scoring for 2 of the items (TTF: time to 
the first cigarette of the day; CPD: number of 
cigarettes smoked per day) was measured to 
help refine our knowledge about the dependen-
cy on tobacco and the means of measuring it.
Data analysis
Data analysis and management were per-
formed using SPSS 17 software (SPSS Inc., 
Chicago, IL, USA). The demographic data was 
described by frequency and percentage. The 
lack of data in one item such as age or the high-
est level of school education was treated as 
missing value. In the questionnaire, the item 
Twentieth (Have you ever smoked cigarettes or 
used another tobacco product daily or almost 
daily?), Twenty-fifth (If you do not currently use 
tobacco, when did you quit?), as well as the 
item Forty-eighth (Do you have any friends or 
family members who have quit smoking or 
other tobacco use?) may lead to the end of the 
questionnaire. Once the questionnaire was ter-
minated, the remaining items in the question-
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naire would be treated as missing values. 
Subjects did not complete the questionnaire 
would be eliminated from the analysis. 
According to a previous publication [19], the 
prevalence of tobacco use in this study was 
described as the percentage of positive sub-
jects among those who accomplished the trial, 
and adjusted prevalence was calculated 
according to the distribution of patients with 
smoking-related problems among all the sub-
jects involved in these issues. Categorical data 
such as difference of prevalence between 
ages, genders, smoking-related conditions, and 
if currently employed, were compared using χ2 
test at the significant level of less than 0.05. 
Consecutive data with normal distribution such 
as age were expressed as mean ± SD and ana-
lyzed using the t-test. The multivariate logistic 
regression analysis was used to assess and 
analyze the relationship between attitude of 
Results 
Demographic characteristics
The study consisted of 100 hospitalized psychi-
atric patients; one was excluded due to the 
incompletely answered questionnaire. 57 of 
them were male and 36 were female patients. 
The ages range from 15 to 69 years (mean, 
40.0 ± 11.5). The demographic characteristics 
of tobacco use among the study patients were 
presented in Figure 1. Among the inpatients 
with mental illnessess, there was a higher 
smoking rate between 36 and 45 years than 
other age groups, accounting for about 41.41% 
(Figure 1A), which was significantly higher than 
other groups (p < 0.05). The prevalence of 
smoking was significantly higher in male 
(40.4%) than female (23.9%). At the time of 
review, 45.5% of patients were unemployed. 
They were either looking for work, or already 
retired, for these unemployed patients, dis-
Figure 1. Prevalence of tobacco use among hospitalized psychiatric patients. Of the inpatients with mental illness, 
smoking rate (prevalence) in different: age groups (A); unemployed status (B); marital status (C); and education 
status (D).
Table 1. Demographic characteristics of tobacco use 






Schizophrenia 40 48 3
Depression 35 42 2
Anxiety disorders 10 25 3
Drug dependence 15 65 3
psychiatric patients toward tobacco use 
and their education status.
After clinicians finished diagnosis of psy-
chotic disorder in patients, “recognized” or 
“detected” were defined according to ICD-
10 criteria, referral including psychiatry or 
psychology departments, and prescription 
of antipsychotic drugs, as well as related 
diseases that can be explicitly excluded.
Tobacco use through ATTOC model
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abled patients have the lowest smoking rate 
when compared with other groups (Figure 1B, p 
< 0.05). As shown in Figure 1C, Smoking preva-
lence was associated with marital status of 
patients, there was a higher proportion of 
smoker among never-married patients than 
those who were married (34.0% vs. 12.4%, p < 
0.05), in addition, widowed patients have a 
higher percentage of smoking (43.3%, p < 0.05 
when compared with married patients). 
Expectedly, patients with higher education 
exhibited a smaller proportion of smokers, we 
observed that patients have bachelor or above 
degree have the lowest smoking rate in each 
group (p < 0.05 when compared with other 
groups, Figure 1D).
Diagnosis of patients with mental illness 
The mental diseases were diagnosed accord-
ing to ICD-10 diagnostic criteria, and further 
conformation and classifications were carried 
out. The statistics shows that tobacco preva-
lence was pretty high among the inpatients suf-
fering from mental illness, especially ones suf-
fering from depression, anxiety disorders, and 
schizophrenia (Table 1). In addition, hospital-
ized psychiatric patients exhibited a family his-
item on a 5-point Likert scale (1 = strongly 
agree, 5 = strongly disagree). For presentation 
of the results, response “strongly agree” was 
collapsed into “agree” and “strongly disagree” 
was collapsed into “disagree”. Survey results 
were presented in Table 4. 
In addition, the relationship between attitude 
toward tobacco use and the level of education 
achieved was assessed and analyzed. Edu- 
cation status of the psychiatric patients was 
classified according to their highest level of 
education achieved, and was used as the 
dependent variable to carry out multivariate 
logistic regression analysis. The data showed 
that the level of education was partially corre-
lated with patients’ attitudes toward using of 
tobacco products (Table 4). 
Relationship between the daily cigarettes 
smoked and other relevant factors 
In hospitalized psychiatric patients, relation-
ship between the number of cigarettes daily 
consumed and other relevant factors, such as 
sex, age, education status, if employed and 
marital status (as described in Figure 1) were 
investigated. The daily cigarettes consumption 








Valid ~10 9 9.1 34.6 34.6
11~20 9 9.1 34.6 69.2
21~30 5 5.1 19.2 88.5
30~ 3 3.0 11.5 100.0
Total* 26 26.3 100.0
Daily cost (yuan)
Valid 0~5 6 6.1 16.7 16.7
6~10 11 11.1 30.6 47.2
10~ 11 11.1 30.6 77.8
Uncertain 8 8.1 22.2 100.0
Total* 36 36.4 100.0
Reasons for smoking
Valid Habit 17 17.2 53.1 53.1
Enjoyment 1 1.0 3.1 56.2
Sociality 3 3.0 9.4 65.6
Relieving stress 8 8.1 25.0 90.6
others 3 3.0 9.4 100.0
Total* 32 32.3 100.0
Note: *-only the patients with valid records were included.
tory of smoking, and were vulnerable 
to relapse after withdrawal. 
Situation of tobacco products use
In the questionnaire, situation on the 
using of tobacco products was investi-
gated in full detail, which including: the 
number of cigarettes smoking per day, 
the cost of tobacco products use per 
day; and others that were not analyzed 
statistically. The data show that most 
smokers consumed a pack of tobacco 
products (20 cigarettes) per day, and 
daily cost of tobacco use was estimat-
ed to be about 10 yuan (Table 2). 
Some patients, however, were not very 
certain about their daily consumption 
on tobacco products (22.2%), and 
data were not available in 63.6 % of 
patients.
Attitude toward tobacco use
Questions used for survey on the atti-
tudes of smoking were summarized in 
Table 3. Participants were asked to 
rate their level of agreement to each 
Tobacco use through ATTOC model
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was used as a target variable, the relevant fac-
tors mentioned-above were taken as indepen-
dent variables to carry out χ2 test. As shown in 
Table 5, there was certain relationship between 
the number of cigarettes daily consumed and 
other relevant factors.
The reasons to smoke tobacco 
The reasons for tobacco smoking were investi-
gated and summarized in Table 2. The most 
frequent answer was their daily habit in 53.1% 
of psychiatric patients, followed by relieving 
stress, accounting for about 25.0%. 
Health care workers and smoking cessation 
activities
In smoking cessation activities, health care 
workers played crucial roles, only if the patients 
themselves thought of quitting. Evaluation of 
the smoking cessation-related activities was 
undertaken by clinicians. The activities were 
arranged according to the clinician services of 
S-KAS [20]. Response codes in health care 
workers services were Never (1), Occasionally 
(2), Often (3), Very Often (4), and Always (5). 
From the data we can see that it was rare case 
for most of the clinicians to arrange and partici-
pate in smoking cessation-related activities 
(Table 6). 
Discussion
The association of tobacco use with mental ill-
ness patients has been reported previously, 
schizophrenia [21], depression [22], as well as 
otherwise alcohol and illicit drug use [23] were 
suggested to be more common risk factors for 
Table 3. Questions used for survey on smoking-related issues
Questions
Survey on the attitudes of patients toward smoking  
NO. 1. The hazards of smoking have been clearly demonstrated.
NO. 2. Smoking light cigarettes is safer than smoking regular cigarettes.
NO. 3. The hazards of second-hand smoke have clearly demonstrated. 
NO. 4. If a person has smoked a pack of cigarettes a day for more than 20 years, there is little health benefit to quitting smoking
NO. 5. Counseling for quitting smoking is an important part of this program’s mission
NO. 6. My clinician or counselor has the required skills to help people in this program quit smoking.
NO. 7. Smoking is a personal decision which does not concern doctor or nurses.
NO. 8. I am aware of community resources to help people quit smoking.
Survey on smoking cessation-related activities
NO. I Arrange for a follow-up appointment to discuss quitting smoking
NO. II Encourage you to quit smoking completely
NO. III Encourage you to use products to help you to quit smoking (nicotine patch, gum, Zyban or bupropion, etc.)
NO. IV Encourage you to reduce smoking to five or fewer cigarettes per day if you have stated that you could not quit. 
Table 4. Attitudes toward smoking and their relationship with education status
Cigarette smoking attitudes (point) Smoking attitudes and education status
Non-standardized Standardized
5/4 (%) 3 (%) 2/1 (%) RC SD RC t value p value
Constant 3.437 .773 4.446 .000
NO. 1. 11/12 (23%) 10 (10%) 35/31 (67%) .214 .130 .209 -1.201 .043
NO. 2. 13/19 (34.4%) 38 (40.9%) 21/2 (24.7%) .031 .162 .011 -1.158 .035
NO. 3. 12/7 (21.1%) 9 (10%) 31/31 (68.9%) -.224 -.137 -.083 -3.201 .011
NO. 4. 26/17 (47.3%) 20 (22.0%) 20/8 (30.8%) -.236 .217 -.055 -.2.106 .034
NO. 5. 7/6 (14.7%) 14 (15.7%) 44/18 (69.7%) .251 .173 .088 -1.877 .047
NO. 6. 10/4 (15.2%) 16 (17.4%) 44/18 (67.4%) .177 .230 .108 -1.003 .031
NO. 7. 18/16 (38.2%) 20 (22.5%) 28/7 (39.3%) .167 .136 .103 -2.001 .347
NO. 8. 9/4 (14.4%) 32 (35.6%) 36/9 (50.0%) -.355 .304 -.207 -2.011 .037
Note: Dependent variables: What is the highest level of school you have completed to date? (Education status). Only when P < 
0.05, there is a significantly difference. 1, Strong agree; 2, Agree; 3, Unsure; 4, Disagree; 5, Strong disagree; Regression coef-
ficient, RC; Standard deviation, SD.
Tobacco use through ATTOC model
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smokers than the non-smokers. To our knowl-
edge, it was the first time that questionnaire 
investigation of the tobacco prevalence were 
carried out among Chinese psychiatric inpa-
tients, and it was also the first time that the fea-
sibility of ATTOC intervention was assessed 
among Chinese population to explore whether 
the intervention model is suitable for Chinese 
tobacco users.
Our survey found that patients with mental ill-
ness showed a high propensity for tobacco use, 
especially for patient with schizophrenic disor-
ders, which account for 40% of all smoking 
patients, this is in consistent with the results 
previous report, that the proportion of schizo-
phrenic smokers was between 40% and 90% 
[24, 25]. This finding also consistent with the 
meeting of Tobacco use and cessation in psy-
chiatric disorders held in U. S. National Institute 
of Mental Health [26]. 
consistent with the previous survey [27], our 
research showed there were a larger percent-
age of male patient smokers than female coun-
terparts, their peak age in smoking prevalence 
was concentrated in the range between 36 and 
45 years. Besides, there was a higher preva-
lence of tobacco smoking among those who 
were unemployed, never-married, or less edu-
cated. Previous studies indicated that people 
with low education were more likely to smoke 
[28], in the United States, the unmarried, low-
educated, and blue-collar were reported to 
have a high risk of smoking. However, there 
was no statistical significant in gender related 
differences [29].
According to the World Health Organization, 
tobacco-related deaths could rise from approxi-
mately 5.0 million in 2004 to 8.0 million in 
2030 [33]. In view of the hazards of tobacco 
products and higher prevalence of tobacco 
smoking among inpatients with mental illness, 
it is urgent to take effective interventions for 
controlling tobacco use. As an effective sys-
tems intervention, ATTOC has been developed 
and refined over years to achieve an effective 
addiction treatment program. 
As the largest tobacco producer and consumer 
around the world, China yet not developed 
effective intervention systems to address 
tobacco use. With ATTOC intervention employed 
in Chinese population, we could explore an 
addiction treatment program that suitable for 
our Chinese population. Our results indicated 
that in Chinese psychiatric patients, smoking 
status of such as smoking age, work status, 
marital status, etc. were consistent with that 
was reported in US. Furthermore, previous 
study suggested that the pattern of smoking in 
China in the 1980s was similar to US. in the 
1950s [34]. According to studies mentioned 
above, it can be postulated that ATTOC inter-
vention program of the US. may be suitable for 
hospitalized Chinese psychiatric patients, and 
ultimately, it could be applied for the tobacco 
smoking treatment in Chinese population. 
There were several limitations in this study. The 
relatively small sample size may be deviations 
to acceptability and comprehension of the 
questionnaire, furthermore, the inevitable cul-
tural differences as well as the lack of knowl-
Table 5. Relationship between the cigarettes smoked daily and 
some relevant factors
sex age education status if employed marital status
χ2 2.216a 18.602b 29.011c 1.372d 56.374e
P .047 .001 .000 .000 .001
Note: a, b, c, d, e: All lattice theory frequency, T values are greater than 5 in four-
fold tables. P < 0.05, there is a significantly difference.
Table 6. Answers given by the patients on the smoking cessation-
related activities
Never (1) Occasionally (2) Often (3) Very Often (4) Always (5)
NO. I 14 1 5 3 1
NO. II 4 9 5 2 3
NO. III 10 4 5 3 2
NO. IV 10 3 3 4 3
Cigarette smoking was a com-
plex behavior, both genetic 
and environmental compo-
nents are involved and corre-
lated [30]. Concerning the rea-
sons for smoking, our study 
showed that most psychiatric 
patients ascribed their tobac-
co use to habits, others were 
enjoyment, sociality, relieving 
stress, or etc. However, tobac-
co smoking wasn’t being 
reported to alleviate the symp-
toms of schizophrenia patients, 
this suggesting that it may 
serve as a form of self-medica-
tion [31, 32].
Tobacco use through ATTOC model
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edge of tobacco products were also limited our 
research in this study.
In conclusion, the present study suggest that 
ATTOC intervention program might be suitable 
for hospitalized Chinese psychiatric patients, 
and it could be applied for the tobacco smoking 
treatment in China. However, the health effects 
of tobacco use still did not draw amount atten-
tions from both the clinicians and general pub-
lic. It is urgently needed to raise people’s aware-
ness and carry out ATTOC intervention to 
control tobacco use, and ultimately terminate 
tobacco use.
Acknowledgements
The authors wish to thank Drs. Liang Xie, 
Yuejing Wu, Wanjun Guo, Bo Zhang, and Jennifer 
Wu and nursers Xia Huang, Xuehua Huang, 
Xiaozhen Song, Qinglan Tao, Ya Wang, Xiaohong 
Gong and Bingrong Cao for for project support. 
This project was funded by a grant of University 
of Massachusetts Medical School Global Initi- 
atives Program. 
Disclosure of conflict of interest
None.
Address correspondence to: Dr. Tao Li, Mental Hea- 
lth Center, West China Hospital of Sichuan University, 
Chengdu, Sichuan 610041, P. R. China. Tel: +86-
18980601866; Fax: +86-28-85422632; E-mail: lit-
aopre@163.com
References
[1] Organization WH. The world health report 
1999: making a difference. World Health Orga-
nization 1999.
[2] Breslau N and Klein DF. Smoking and panic at-
tacks: an epidemiologic investigation. Arch 
Gen Psychiatry 1999; 56: 1141.
[3] Kelly C and McCreadie RG. Smoking habits, 
current symptoms, and premorbid characteris-
tics of schizophrenic patients in Nithsdale, 
Scotland. Am J Psychiatry 1999; 156: 1751-
1757.
[4] Hughes JR, Helzer JE and Lindberg SA. Preva-
lence of DSM/ICD-defined nicotine depen-
dence. Drug Alcohol Depend 2006; 85: 91-
102.
[5] Mokdad AH, Marks JS, Stroup DF and Gerberd-
ing JL. Actual causes of death in the United 
States, 2000. JAMA 2004; 291: 1238-1245.
[6] Hughes JR. Should criteria for drug depen-
dence differ across drugs? Addiction 2006; 
101: 134-141.
[7] McGinnis JM and Foege WH. Actual causes of 
death in the United States. JAMA 1993; 270: 
2207-2212.
[8] Xie B, Palmer PH, Pang Z, Sun P, Duan H and 
Johnson CA. Environmental tobacco use and 
indicators of metabolic syndrome in Chinese 
adults. Nicotine Tob Res 2010; 12: 198-206.
[9] Zhang J, Ou JX and Bai CX. Tobacco smoking in 
China: prevalence, disease burden, challenges 
and future strategies. Respirology 2011; 16: 
1165-1172.
[10] Ostacher MJ, LeBeau RT, Perlis RH, Nierenberg 
AA, Lund HG, Moshier SJ, Sachs GS and Simon 
NM. Cigarette smoking is associated with sui-
cidality in bipolar disorder. Bipolar Disord 
2009; 11: 766-771.
[11] Lawrence D, Mitrou F and Zubrick SR. Smoking 
and mental illness: results from population 
surveys in Australia and the United States. 
BMC Public Health 2009; 9: 285.
[12] Hoffman AL and Slade J. Following the pio-
neers: Addressing tobacco in chemical depen-
dency treatment. J Subst Abuse Treat 1993; 
10: 153-160.
[13] Kozlowski L, Jelinek L and Pope M. Cigarette 
smoking among alcohol abusers: a continuing 
and neglected problem. Can J Public Health 
1986; 77: 205.
[14] Schroeder SA and Morris CD. Confronting a ne-
glected epidemic: tobacco cessation for per-
sons with mental illnesses and substance 
abuse problems. Annu Rev Public Health 
2010; 31: 297-314. 
[15] Kendrick JS and Merritt RK. Women and smok-
ing: an update for the 1990s. Am J Obstet Gy-
necol 1996; 175: 528-535.
[16] Mezzich JE. International surveys on the use of 
ICD-10 and related diagnostic systems. Psy-
chopathology 2002; 35: 72-75.
[17] Guydish J, Ziedonis D, Tajima B, Brigham G, 
Zammarelli L, Levy M, editors. Addressing nico-
tine dependence in drug treatment settings: 
Organizational change. Poster presented at 
the annual meeting of the College on Problems 
of Drug Dependence, in Reno Nevada; 2009.
[18] Heatherton TF, Kozlowski LT, Frecker RC and 
FAGERSTROM KO. The Fagerström test for nic-
otine dependence: a revision of the Fager-
strom Tolerance Questionnaire. Br J Addict 
1991; 86: 1119-1127.
[19] He Y, Ma H, Zhang L, Liu Z, Jia F and Zhang M. 
A cross-sectional survey of the prevalence of 
depressive-anxiety disorders among general 
hospital outpatients in five cities in China. 
Zhonghua Nei Ke Za Zhi 2009; 48: 748-751.
[20] Guydish J, Tajima B, Chan M, Delucchi KL and 
Ziedonis D. Measuring smoking knowledge, at-
titudes and services (S-KAS) among clients in 
addiction treatment. Drug Alcohol Depend 
2011; 114: 237-241.
Tobacco use through ATTOC model
6015 Int J Clin Exp Med 2015;8(4):6008-6015
[21] de Leon J, Dadvand M, Canuso C, White AO, 
Stanilla JK, Simpson GM. Schizophrenia and 
smoking: an epidemiological survey in a state 
hospital. Am J Psychiatry 1995; 152: 453-455.
[22] Kendler KS, Neale MC, MacLean CJ, Heath AC, 
Eaves LJ and Kessler RC. Smoking and major 
depression: a causal analysis. Arch Gen Psy-
chiatry 1993; 50: 36-43.
[23] Istvan J and Matarazzo JD. Tobacco, alcohol, 
and caffeine use: a review of their interrela-
tionships. Psychol Bull 1984; 95: 301.
[24] Kalman D, Morissette SB and George TP. Co-
Morbidity of Smoking in Patients with Psychiat-
ric and Substance Use Disorders. Am J Addict 
2005; 14: 106-123.
[25] de Leon J and Diaz FJ. A meta-analysis of 
worldwide studies demonstrates an associa-
tion between schizophrenia and tobacco 
smoking behaviors. Schizophr Res 2005; 76: 
135-157.
[26] Ziedonis D, Hitsman B, Beckham JC, Zvolensky 
M, Adler LE, Audrain-McGovern J, Breslau N, 
Brown RA, George TP and Williams J. Tobacco 
use and cessation in psychiatric disorders: Na-
tional Institute of Mental Halth report. Nicotine 
Tob Res 2008; 10: 1691-1715. 
[27] Lee S, Guo WJ, Tsang A, Huang YQ, He YL, Kes-
sler RC. Prevalence and correlates of active 
and ever-smokers in metropolitan China. Ad-
dict Behav 2009; 34: 969-972.
[28] Yang G, Ma J, Liu N and Zhou L. [Smoking and 
passive smoking in Chinese, 2002]. Zhonghua 
Liu Xing Bing Xue Za Zhi 2005; 26: 77-83.
[29] Ziedonis DM, Zammarelli L, Seward G, Oliver K, 
Guydish J, Hobart M and Meltzer B. Addressing 
tobacco use through organizational change: A 
case study of an addiction treatment organiza-
tion. J Psychoactive Drugs 2007; 39: 451-459.
[30] Sullivan PF and Kendler KS. The genetic epide-
miology of smoking. Nicotine Tob Res 1999; 1: 
S51-S57.
[31] Leonard S, Mexal S and Freedman R. Smoking, 
genetics and schizophrenia: evidence for self 
medication. J Dual Diagn 2007; 3: 43.
[32] Winterer G. Why do patients with schizophre-
nia smoke? Curr Opin Psychiatry 2010; 23: 
112-119.
[33] Kaleta D, Kozieł A, Miśkiewicz P. [MPOWER-
-strategy for fighting the global tobacco epi-
demic]. Med Pr 2009; 60: 145-9. 
[34] Yu JJ, Mattson ME, Boyd GM, Mueller MD, Sho-
pland DR, Pechacek TF and Cullen JW. A com-
parison of smoking patterns in the People’s 
Republic of China with the United States. JAMA 
1990; 264: 1575-1579. 
